Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis: reply
J Thromb Haemost
.
2016 Jan;14(1):221-3.
doi: 10.1111/jth.13180.
Epub 2016 Jan 6.
Authors
N Veronese
1
,
G Bano
1
,
S Granziera
1
,
M Solmi
2
3
,
A T Cohen
4
,
C U Correll
5
6
7
8
Affiliations
1
Department of Medicine, Geriatrics Section, University of Padova, Padova, Italy.
2
Department of Neurosciences, University of Padova, Padova, Italy.
3
National Research Council, Aging Branch, Institute of Neuroscience, Padova, Italy.
4
Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, London, UK.
5
The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System, Glen Oaks, New York, USA.
6
Hofstra North Shore LIJ School of Medicine, Hempstead, New York, USA.
7
The Feinstein Institute for Medical Research, Manhasset, New York, USA.
8
Albert Einstein College of Medicine, Bronx, New York, USA.
PMID:
26554746
DOI:
10.1111/jth.13180
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants / adverse effects*
Female
Fractures, Spontaneous / etiology*
Humans
Male
Osteoporosis / chemically induced*
Vitamin K / antagonists & inhibitors*
Substances
Anticoagulants
Vitamin K